seed
Stage
About
LoopDX develops an in vitro cellular immunoassay diagnostic tool for early detection of sepsis by identifying immune activity biomarkers within the first hour of bloodstream infection, enabling timely treatment to reduce severity and mortality.
Explore LoopDX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.